Keudell Vertex Pharmaceuticals Inc Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Keudell holds 646 shares of VRTX stock, worth $300,105. This represents 0.08% of its overall portfolio holdings.

Number of Shares

646

Previous 931 30.61%

Holding current value

$300,105

Previous $436,000 31.19%

% of portfolio

0.08%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$460.0 - $505.78 $131,100 - $144,147	-285 Reduced 30.61%	646 $300,000
Q2 2024 Jul 16, 2024	SELL	$392.81 - $485.53 $23,175 - $28,646	-59 Reduced 5.96%	931 $436,000
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $4,076 - $4,460	-10 Reduced 1.0%	990 $413,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $17,150 - $20,534	-50 Reduced 4.76%	1,000 $406,000
Q3 2023 Oct 18, 2023	SELL	$338.18 - $362.46 $15,894 - $17,035	-47 Reduced 4.28%	1,050 $365,000
Q2 2023 Jul 20, 2023	SELL	$314.42 - $351.91 $37,101 - $41,525	-118 Reduced 9.71%	1,097 $386,000
Q1 2023 Apr 18, 2023	BUY	$283.23 - $323.1 $34,837 - $39,741	123 Added 11.26%	1,215 $382,000
Q4 2022 Jan 20, 2023	SELL	$285.76 - $321.48 $33,433 - $37,613	-117 Reduced 9.68%	1,092 $0
Q3 2022 Oct 12, 2022	SELL	$273.83 - $305.53 $39,157 - $43,690	-143 Reduced 10.58%	1,209 $350,000
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $20,206 - $25,159	-86 Reduced 5.98%	1,352 $381,000
Q1 2022 Apr 18, 2022	BUY	$221.42 - $260.97 $11,735 - $13,831	53 Added 3.83%	1,438 $375,000
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $53,634 - $67,705	-303 Reduced 17.95%	1,385 $304,000
Q3 2021 Oct 20, 2021	SELL	$181.39 - $202.99 $7,436 - $8,322	-41 Reduced 2.37%	1,688 $306,000
Q2 2021 Jul 13, 2021	BUY	$187.49 - $221.1 $8,999 - $10,612	48 Added 2.86%	1,729 $349,000
Q1 2021 Apr 13, 2021	BUY	$207.02 - $241.31 $5,175 - $6,032	25 Added 1.51%	1,681 $361,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $51,131 - $68,194	247 Added 17.53%	1,656 $391,000
Q3 2020 Oct 20, 2020	BUY	$255.65 - $303.1 $39,625 - $46,980	155 Added 12.36%	1,409 $383,000
Q2 2020 Jul 14, 2020	BUY	$225.48 - $295.8 $83,202 - $109,150	369 Added 41.69%	1,254 $364,000
Q1 2020 Apr 20, 2020	SELL	$199.77 - $247.81 $10,188 - $12,638	-51 Reduced 5.45%	885 $211,000
Q4 2019 Jan 29, 2020	BUY	$166.71 - $223.91 $156,040 - $209,579	936 New	936 $205,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account